Link to this page
Medical Subject Headings
Last uploaded:
January 16, 2025
Jump to:
Id | http://purl.bioontology.org/ontology/MESH/D000068338
http://purl.bioontology.org/ontology/MESH/D000068338
|
---|---|
Preferred Name | Everolimus |
Definitions |
A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT.
|
Synonyms |
RAD001
RAD 001
Afinitor
Certican
SDZ RAD
SDZ-RAD
Zortress
40-O-(2-hydroxyethyl)-rapamycin
001, RAD
RAD, SDZ
|
Type | http://www.w3.org/2002/07/owl#Class |
All Properties
definition | A derivative of sirolimus and an inhibitor of TOR SERINE-THREONINE KINASES. It is used to prevent GRAFT REJECTION in heart and kidney transplant patients by blocking cell proliferation signals. It is also an ANTINEOPLASTIC AGENT. |
---|---|
altLabel |
RAD001
RAD 001
Afinitor
Certican
SDZ RAD
SDZ-RAD
Zortress
40-O-(2-hydroxyethyl)-rapamycin
001, RAD
RAD, SDZ
See more
See less
|
prefLabel |
Everolimus
|
TH |
NLM (1997)
NLM (2016)
NLM (2009)
NLM (2023)
NLM (2001)
NLM (2003)
See more
See less
|
notation |
D000068338
|
DX |
20160101
|
Machine permutation |
2016; EVEROLIMUS was indexed under SIROLIMUS 1998-2015; and under POLYENES 1997-1998
|
MN |
D02.540.505.760.500
|
PA |
D000091203
D007166
|
MMR |
20220714
|
Mapped from | |
AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
HN |
2016 (1997)
|
subClassOf | |
Semantic type UMLS property | |
Inverse of RB |
9HW64Q8G6G
0
|
LT |
TRD
|
DC |
1
|
MDA |
20150701
|
type | |
tui |
T109
T121
|
cui |
C2682856
C5200978
C2756938
C1174751
C0541315
C0962969
See more
See less
|
isa | |
Inverse of AQ |
See more
See less
|
TERMUI |
T534925
T001113751
T308864
T308863
T754038
T000875190
T432424
T000875191
T544057
See more
See less
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |